ESRRA and endometrial cancer: The estrogen-related receptor α (ERRα) drives lipid metabolism, together with PGC1α/PPAR; nevertheless, recent evidence shows that ERRα is a direct target of TFEB, and both are overexpressed in patients with endometrial cancer [41].